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Results: There were 23 consultations performed for
hand ischemia related to radial artery catheters. Compared to
nonischemic controls consulted patients were more likely to
have shock (P.002), sepsis (P.01), and be receiving anti-
coagulation (P.04). Twelve patients (52%) required surgical
revascularization; thrombectomy (91.7%), intraoperative
thrombolysis (58.3%), vein patch angioplasty (33.3%), and
intraoperative angiography (50%). In patientswhounderwent
revascularization, 2 required digital amputation, 1 required
major upper extremity amputation, and 2 patients died. In
patients who underwent nonoperative management, none
required amputation. Overall mortality was 22% in patients
requiring vascular consultation and 17% in those requiring
operation for radial artery catheter ischemic complications.
Conclusions: Fifty-two percent of patients with isch-
emic complications of radial artery catheters require oper-
ation and mortality is high. Patients with shock and sepsis
are more likely to develop radial catheter-associated upper
extremity ischemia. Those requiring revascularization have
a high rate of digital or major upper extremity amputation.
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SS1.
Impact of Transfusion and Nadir Postoperative Hemo-
globin on Short- and Long-term Outcomes after Inter-
ventions for Peripheral Arterial Disease (PAD)
Panos Kougias1, Sonia Orcutt2, Peter H. Lin2, George
Pisimisis1, Neal R. Barshes1, Carlos F. Bechara1. 1Michael
E. DeBakey VAMC, Houston, TX; 2Baylor College of
Medicine, Houston, TX
Objectives: Controversy surrounds the topic of trans-
fusion policy after non-cardiac operations. This study as-
sessed the combined impact of postoperative nadir hemo-
globin (nHb) levels and blood transfusion on adverse
events after open surgical intervention in patients with
PAD.
Methods: Consecutive patients (n1182) who under-
went PAD-related operations were matched on propensity
scores calculated as their probability to have nHb more or
less than 10gm/dl on the basis of operation type, demo-
graphics and comorbidities, including the revised cardiac
risk index. Logistic and Cox proportional hazards regres-
sions were used to assess the impact of nHb and number of
transfused units on 1) a composite endpoint (CE) of death,
myocardial infarction and stroke; 2) respiratory and wound
complications.
Results: After adjusting for nHb level, the number of
units transfused was a strong predictor for the perioperative
occurrence of the CE (OR,1.12, P.02) and respiratory
complications (OR, 1.27, P.004). Adjusted for the num-
ber of units transfused, nHb had no impact on the periop-
erative CE (OR, 0.6, P.3) or respiratory events (OR,
0.40, P.17). An interaction term between transfusion and
nHb level remain non-significant (P.543), indicating that
the impact of blood transfusion was the same regardless of
nHb level. Perioperative wound infections were less com-
mon in patients with nHb 10gm/dl (OR, 0.59, P.04),
whereas transfusion had no impact on wound infection
rates (OR, 0.98, P.84). During an average follow up of
24 months transfused patients were more likely to develop
the CE (HR, 1.13, P.02), whereas nHb level did not
impact the long term adverse event rate (HR, 0.7, P.26).
Conclusions: Blood transfusion increases the inci-
dence of perioperative and long-term mortality and cardio-
vascular adverse events regardless of the associated nHb. It
also increases the risk of perioperative respiratory compli-
cations. A restrictive transfusion strategy is justified in pa-
tients with PAD.
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The Impact of Arterial Pedal Arch Quality and Angio-
some Revascularization on the Outcome of Distal By-
pass Surgery
Hani Slim, Hany Zayed, Michael Edmonds, Hisham
Rashid. Vascular Surgery, King’s Collage Hospital, Lon-
don, United Kingdom
Objectives: To evaluate the impact of pedal arch qual-
ity on the amputation-free survival and patency rates of
distal bypass grafts and also its direct impact on rate of
healing and time-to-healing of tissue loss following direct
angiosome revascularization in patients with critical limb
ischemia (CLI).
Methods:Between 2004 and 2011, patients undergoing
distal bypass for CLI (Rutherford 4-6) were divided in groups
taking in consideration the state of the pedal arch and direct
angiosome revascularization (DAR) and non-DAR. Based on
angiography, the pedal arch was divided into 3 groups; com-
plete pedal arch (CPA), incomplete pedal arch (IPA) and no
pedal arch (NPA). Kaplan-Meier was used to analyse patency
rates at 12months, amputation-free survival at 48months, the
rate of healing and time-to-healing of tissue loss.
Results: Total of 167 bypasses was included in the
analysis. 31(19%) had CPA, 104 (62%) IPA and 32 (19%)
had NPA. Incidence of diabetes mellitus and chronic renal
failure was similar in all groups. The primary and secondary
patency rates at 1-year as well as the amputation-free sur-
vival at 48 months for all groups were: CPA, 58.4%, 86.0%
and 67.2% (P.5168); IPA, 54.6%, 84.7% and 69.7%
(P.8940); and NPA, 63.8%, 88.8% and 45.9%
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(P.3883). Out of the 167 bypasses, 141 had foot tissue
loss. In the CPA group 93% of tissue loss with DAR healed
(median time-to-healing; 56 days) compared to 100% in
the non-DAR (98 days). Similarly in the IPA group 95%
with DAR healed (106 days) compared to 90% in the
non-DAR (94 days). While in the NPA group only 75%
with DAR healed (81 days) compared to 73% in the non-
DAR (148 days). There was only statistical significant dif-
ference in the time-to-healing between CPA/IPA versus
NPA group (P.0141).
Conclusions: The quality of the pedal arch did not
influence the patency or the amputation-free survival rates.
However, the healing and time-to-healing rates were di-
rectly influenced by the quality of the pedal arch rather than
the angiosome revascularized.
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Video Presentation
Ultrasound for the Diagnosis and Treatment of Popli-
teal Entrapment Syndrome
Marlin W. Causey, Thomas Curry, Reagan Quan, Charles
Andersen, Niten Singh.Madigan ArmyMedical Center, Ft.
Lewis, WA
Background: Popliteal Entrapment Syndrome is a rare
cause of claudication in the young population. These pa-
tients are typically referred to multiple specialists prior to
their diagnosis and optimal treatment. Ultrasound has
commonly been used as an adjunct to clinical diagnosis in
most outpatient clinics. We describe additional techniques
of using intravascular ultrasound for diagnosis when an-
giography is performed.More importantly, this video high-
lights the intraoperative use of ultrasound to ensure an
adequate and optimal myectomy when treating popliteal
entrapment syndrome as well as an ability to survey the
arterial wall for intimal injury with B mode duplex.
Technical Description: Patients are most commonly
diagnosed clinically with popliteal entrapment syndrome.
During the time of angiography, intravascular ultrasound is
able to demonstrated distinct compression of the popliteal
artery with active plantar flexion. Palpation has traditionally
been used to assess the adequacy of resection for popliteal
entrapment but this may prove to be inadequate with some
patients and intraoperative ultrasound allows assessment of
the adequacy of resection. We also perform B mode duplex
after complete resection to survey for intimal changes that
may not have been seen during the preoperative workup.
Author Disclosures: C. Andersen: Nothing to disclose;
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Infrapopliteal Angioplasty for Critical Limb Ischemia:
Results at 5-year Follow-up
Ruby C. Lo, Rodney P. Bensley, Kristina A. Giles, Jeremy
D. Darling, MarkWyers, Allen D. Hamdan, Elliot Chaikof,
Marc L. Schermerhorn. Beth Israel Deaconess Medical
Center, Boston, MA
Objectives: Infrapopliteal angioplasty (PTA) is rou-
tinely used to treat critical limb ischemia (CLI) despite
limited data on long-term outcomes.
Methods: We reviewed all patients undergoing infr-
apopliteal PTA for CLI from 2004 to 2011 stratified by
TASC class. Outcomes included restenosis, primary pa-
tency, reintervention (w/ PTA or bypass), amputation,
complications, and survival.
Results: Infrapopliteal PTA (stenting 14%, multilevel
intervention 50%) was performed in 447 limbs of 401
patients (59% male) with technical success of 95% and
perioperative complications in 11%. TASC composition
was 17% A, 22% B, 29% C, and 35% D. All technical failures
involved TASC D lesions. Mean follow-up was 15 months.
5-year survival was 46%. One- and 5-year primary patency
was 55% & 36% and limb salvage was 84% & 81%. Reste-
nosis was associated with TASC C (HR 2.1, 95%CI 1.1-
3.8, P.021) and TASC D (HR 2.1, 95%CI 1.0-4.0,
P.036) lesions. Amputation rates were higher in patients
who were not candidates for bypass (HR 4.3, 95%CI 2.5-
7.3, P.001) and with TASC D lesions (HR 3.7, 95%CI
1.1-12.4, P.032). Together, freedom from restenosis,
revascularization or amputation was predicted by bypass
non-candidacy (HR 1.6, 95%CI 1.1-2.4, P.007) and
TASC C (HR 1.8, 95%CI 1.1-3.0, P.024) and TASC D
(HR 2.0, 95%CI 1.2-3.3, P.011) lesions but not multi-
level intervention (HR .9, 95%CI 0.6-1.2, P.462).
Conclusions: Infrapopliteal PTA is effective primary
therapy for TASC A and B lesions. Multilevel intervention
does adversely affect outcome.
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